Germline alterations in the CLSPN gene in breast cancer families.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Letters

• Publication date

  2008-03-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CANLET.2007.11.003PMID 18077083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of claspin as a proliferation marker in human cancer and normal tissues

  2007cited by this paper
• A recurrent mutation in PALB2 in Finnish cancer families

  2007cited by this paper
• Role of Claspin in regulation of nucleotide excision repair factor DDB2.

  2007cited by this paper
• Hereditary Breast Cancer

  2007cited by this paper
• Linking PCNA-dependent replication and ATR by human Claspin.

  2007cited by this paper
• Polymorphisms of short tandem repeat of genes and breast cancer susceptibility.

  2007cited by this paper
• Chk1 is required to maintain Claspin stability

  2006cited by this paper
• Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

  2006cited by this paper
• DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system.

  2005cited by this paper
• Claspin, a regulator of Chk1 in DNA replication stress pathway.

  2004cited by this paper
• Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation.

  2004cited by this paper
• ATR, Claspin and the Rad9-Rad1-Hus1 Complex Regulate Chk1 and Cdc25A in the Absence of DNA Damage

  2004cited by this paper
• Human Claspin Is a Ring-shaped DNA-binding Protein with High Affinity to Branched DNA Structures*

  2004cited by this paper
• Breast and ovarian cancer.

  2003cited by this paper
• Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility

  2003cited by this paper
• Human Claspin Is Required for Replication Checkpoint Control*

  2003cited by this paper
• A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

  2002cited by this paper
• Germline mutations of the BRCA1‐associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations

  2002cited by this paper
• Mutation analysis of the CHK2 gene in families with hereditary breast cancer

  2001cited by this paper
• Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

  2001cited by this paper
• Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts.

  2000cited by this paper
• Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.

  1998cited by this paper
• The genetics of breast cancer susceptibility.

  1998cited by this paper
• Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing.

  1998cited by this paper
• The genetic attributable risk of breast and ovarian cancer

  1996cited by this paper
• The genetics of breast and ovarian cancer.

  1995cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Transcriptional activation modulated by homopolymeric glutamine and proline stretches.

  1994cited by this paper

• Claspin and Cancer: Where Are We Now?

  2025cites this paper
• Genetic Predisposition to Male Breast Cancer.

  2024cites this paper
• Integrated analysis of -omic landscapes in breast cancer subtypes

  2024cites this paper
• Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers

  2023cites this paper
• A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers

  2023cites this paper
• Implications of CLSPN Variants in Cellular Function and Susceptibility to Cancer

  2020cites this paper
• Claspin: From replication stress and DNA damage responses to cancer therapy.

  2019cites this paper
• Regulation of checkpoint kinase signalling and tumorigenesis by the NF-κB regulated gene, CLSPN

  2018cites this paper
• Claspin – checkpoint adaptor and DNA replication factor

  2018cites this paper
• Claspin functions in cell homeostasis-A link to cancer?

  2017cites this paper
• Extensive variation between tissues in allele specific expression in an outbred mammal

  2015cites this paper
• The Binding Sites of miR-619-5p, miR-5095, miR-5096 and miR-5585-3p in the Human mRNAs

  2014cites this paper
• Population-scale analysis of human microsatellites reveals novel sources of exonic variation.

  2013cites this paper
• Homologous Recombination in Mammals

  2013cites this paper
• Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining.

  2012cites this paper
• AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers

  2010cites this paper
• Molecular analysis of claspin function in vertebrate cells

  2010cites this paper
• Prevalence and Functional Analysis of Sequence Variants in the ATR Checkpoint Mediator Claspin

  2009cites this paper
• CLSPN AND PALB 2 GENES IN FAMILIAL BREAST CANCER SUSCEPTIBILITY

  2008cites this paper
• TOPBP1 , CLSPN and PALB2 genes in familial breast cancer susceptibility

  2008cites this paper
• Towards finding the complete modulome: density constrained biclustering

  2008cites this paper